Searched for
MAKKAPATI
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330ICICI Securities has downgraded Aurobindo Pharma to 'Add' with a revised target price of Rs 1,330, citing potential decline in gRevlimid sa...- Aurobindo Pharma to commence supplies to Europe from China plant in AprilAurobindo Pharma will start supplying products from its new China facility to Europe by April 2024. The company is ramping up production af...
- Buy Aurobindo Pharma, target price Rs 1,755: JM FinancialJM Financial recommends buying Aurobindo Pharma with a target price of Rs 1755, up from the current Rs 1173.7, due to expected growth from ...
- Overweight on Aurobindo Pharma, target price Rs 1,500: Axis SecuritiesAxis Securities gives an overweight call on Aurobindo Pharma with a target price of Rs 1,500. The current market price is Rs 1173.85. The c...
Load More